Nivesh Model Portfolio Tracker

Please note the following changes made in our model portfolios:
Conservative Portfolio:

Sharon Bio‐Medicine Bought @ Rs58 with target price of Rs.74 Reason: Rationale Attached

Sharon Bio Medicine Booster dose of profits doubling in next 2 years

Sharon Bio Medicine (Sharon) is an integrated pharmaceutical company engaged into manufacture of API & formulations. The company has plants out of which are plants based out of Taloja in Maharashtra Formulations plant located at Dehradun, Uttrakhand. All the facilities are approved by UK, Latin America etc. but none by USFDA as of now. However the company is waiting for USFDA approval for its formulation facility. We have recently met the management & come out extremely positive from the meeting. We believe the company is poised for a very strong growth going ahead. The company is changing its strategy from being API dominated company to Formulation driven. Approval from USFDA will be a strong rerating trigger for the stock.

Download Nivesh Model Portfolio July 2014